Today

Agents

Chat

Arena

Discover

More

App

Parabilis Medicines appoints Craig L. Tendler to board of directors

PBLS•2026-11-12

Parabilis Medicines appointed Craig L. Tendler to its board in August 2026. Tendler has oncology drug development experience.

1. Board appointment

Parabilis Medicines appointed Craig L. Tendler to its board of directors in August 2026. The company said he has oncology drug development experience.

Related News

AIM ImmunoTech CEO Thomas K. Equels reports acquiring $5,382 in shares

AIM•2026-11-12

Falcon's Beyond Q3 net loss narrows to $7.7 million; revenue rises 80% to $7.3 million

FBYD•2026-11-12

AudioCodes CEO Shabtai Adlersberg reports $143,408.60 share acquisition

•

2026-11-12

Wall Street set to dip as Nvidia storm continues, Treasury yields bob at 5%

SPY•2026-11-12

Astec Industries agrees to sell Roadtec business to Komatsu for $75 million

ASTE•2026-11-12

Parabilis Medicines appoints Craig L. Tendler to board of directors - PBLS News | Rallies